TAVNEOS

This brand name is authorized in Estonia, Ireland, Israel, Japan, Poland

Active ingredients

The drug TAVNEOS contains one active pharmaceutical ingredient (API):

1 Avacopan
UNII O880NM097T - AVACOPAN

Avacopan is a selective antagonist of the human complement 5a receptor (C5aR1 or CD88) and competitively inhibits the interaction between C5aR1 and the anaphylatoxin C5a. The specific and selective blockade of C5aR1 by avacopan reduces the pro-inflammatory effects of C5a, which include neutrophil activation, migration, and adherence to sites of small blood vessel inflammation, vascular endothelial cell retraction and permeability.

Read about Avacopan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TAVNEOS Hard capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L04AJ05 L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AJ Complement inhibitors
Discover more medicines within L04AJ05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1877261, 1877272
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 9254
Country: JP 医薬品医療機器総合機構 Identifier(s): 3999056M1026
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100465431
Country: US FDA, National Drug Code Identifier(s): 73556-168

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.